Aspira Womens Health Stock Today
AWH Stock | USD 0.89 0.08 9.88% |
Performance0 of 100
| Odds Of DistressLess than 42
|
Aspira Womens is trading at 0.89 as of the 30th of November 2024. This is a 9.88 percent increase since the beginning of the trading day. The stock's open price was 0.81. Aspira Womens has about a 42 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Aspira Womens Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 27th of June 1996 | Category Healthcare | Classification Health Care |
Aspira Womens Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. Aspira Womens Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas. The company has 16.67 M outstanding shares of which 516.18 K shares are presently shorted by investors with about 4.15 days to cover. More on Aspira Womens Health
Moving against Aspira Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Aspira Stock Highlights
CEO President | Nicole CPA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAspira Womens can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aspira Womens' financial leverage. It provides some insight into what part of Aspira Womens' total assets is financed by creditors.
|
Aspira Womens Health (AWH) is traded on NASDAQ Exchange in USA. It is located in Building III, Austin, TX, United States, 78738 and employs 64 people. Aspira Womens is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 14.83 M. Aspira Womens Health runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 16.67 M outstanding shares of which 516.18 K shares are presently shorted by investors with about 4.15 days to cover.
Aspira Womens Health has about 20.48 M in cash with (15.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18.
Check Aspira Womens Probability Of Bankruptcy
Ownership AllocationAspira Womens holds a total of 16.67 Million outstanding shares. Aspira Womens Health retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aspira Ownership Details
Aspira Stock Institutional Holders
Instituion | Recorded On | Shares | |
M&t Bank Corp | 2024-06-30 | 15 K | |
Two Sigma Securities, Llc | 2024-06-30 | 13.5 K | |
Squarepoint Ops Llc | 2024-06-30 | 12.3 K | |
Hrt Financial Llc | 2024-06-30 | 10.9 K | |
Tower Research Capital Llc | 2024-06-30 | 6.7 K | |
Morgan Stanley - Brokerage Accounts | 2024-06-30 | 4.8 K | |
Royal Bank Of Canada | 2024-06-30 | 2.3 K | |
Advisor Group Holdings, Inc. | 2024-06-30 | 2.3 K | |
Jpmorgan Chase & Co | 2024-06-30 | 2.1 K | |
Armistice Capital, Llc | 2024-09-30 | 1.3 M | |
Vanguard Group Inc | 2024-09-30 | 274.1 K |
Aspira Womens Historical Income Statement
Aspira Stock Against Markets
Aspira Womens Corporate Management
Michelle Snider | Senior Operations | Profile | |
Ryan MD | Chief Officer | Profile | |
Emily Granger | Director Marketing | Profile | |
Robert CPA | Chief Officer | Profile | |
Michael Newton | VP Commercial | Profile | |
Marlene McLennan | Interim Officer | Profile |
Already Invested in Aspira Womens Health?
The danger of trading Aspira Womens Health is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aspira Womens is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aspira Womens. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aspira Womens Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aspira Womens Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aspira Womens' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aspira Womens Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aspira Womens Health Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Revenue Per Share 0.801 | Quarterly Revenue Growth (0.03) | Return On Assets (1.86) | Return On Equity (7.23) |
The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womens' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.